AC IMMUNE SA SF-02 Financial Flexibility Index
AC IMMUNE SA SF-02 financial flexibility index. AC IMMUNE SA SF-02 (IMR) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of €-16.40 Million (operating CF €-16.51 Million minus capex €107.00K) represents 0% of total liabilities (€109.37 Million). See AC IMMUNE SA SF-02 (IMR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of AC IMMUNE SA SF-02 (2021–2025)
Financial flexibility index of AC IMMUNE SA SF-02 from 2021 to 2025. Historical Financial Flexibility Index trend for AC IMMUNE SA SF-02 across 5 annual periods. Check AC IMMUNE SA SF-02 (IMR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
AC IMMUNE SA SF-02 Financial Flexibility Index by Year (2021–2025)
AC IMMUNE SA SF-02 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for AC IMMUNE SA SF-02. For the full cash flow conversion analysis, see AC IMMUNE SA SF-02 operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.63x | €-68.36 Million | €-69.26 Million | €109.37 Million | ▼ -211.7% |
| 2024 | 0.56x | €66.42 Million | €65.84 Million | €118.64 Million | ▲ +120.8% |
| 2023 | -2.69x | €-59.61 Million | €-60.41 Million | €22.17 Million | ▲ +37.0% |
| 2022 | -4.27x | €-72.33 Million | €-73.57 Million | €16.95 Million | ▼ -99.4% |
| 2021 | -2.14x | €-63.05 Million | €-65.69 Million | €29.46 Million | — |